4baseCare
Oncology Research | Healthcare and Genomics Company | 4baseCare.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| investor investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
* | $1.0m Valuation: $30.0m | Early VC | |
| Total Funding | 000k | ||
Related Content
4baseCare is a pioneering company in the field of precision oncology, focusing on the Asian market. The company specializes in developing advanced genomics and next-generation digital health technologies to offer personalized cancer care. Their core product includes comprehensive genomic panels that enable oncologists to select the most effective targeted therapies for their patients. By collaborating with tech partners in IT, Data Science, and Genomics, 4baseCare aims to solve complex cancer problems and improve clinical outcomes. The company also works closely with community partners and NGOs to provide emotional support, counseling, and allied care to cancer patients and their families.
4baseCare operates on a B2B2C (Business to Business to Consumer) model, primarily serving healthcare providers, hospitals, and oncology specialists. Revenue is generated through the sale of genomic panels, digital health solutions, and collaborative partnerships.
Keywords: precision oncology, genomics, digital health, targeted therapy, cancer care, Asian market, clinical outcomes, emotional support, B2B2C model, healthcare providers.